HealthTechConnect Global

???Digital therapeutics: The future of hormonal health? Unlike general health apps that focus on fitness or wellness,?Xantial - Digital Therapeutics (DTx) )?are?clinically validated, often regulated, and designed to deliver evidence-based medical interventions. ???? One area where DTx holds?huge promise??Hormonal health.???? In this guest article, founder Victoria Schoeffel shares the story behind Belle Health—a platform that combines?cycle tracking, symptom management, and cognitive-behavioral therapy (CBT) tools?to help individuals better manage?premenstrual disorders. ???? With growing recognition of the impact of?hormonal health on overall well-being, solutions like Belle Health could be a?game-changer?for those struggling with cycle-related symptoms. hashtag #Femtech #DigitalTherapeutics #HormonalHealth #HealthTech #Innovation

???Track Your Period—And Your Impact??? Menstrual cup company?Asan?has just launched a?free period tracking app—but with a?game-changing twist. ?? It includes a?first-of-its-kind environmental tracker, helping users see the?carbon footprint of their period products?in real time. As?Ira Guha, Founder of Asana, explains: ???"Our environmental tracker is all about driving behavior change. In the UK alone, we flush?2 billion tampons per year, and globally, the numbers are even higher. By giving users an easy way to track their period’s carbon footprint, we hope to drive up adoption of reusable options like Asan cups and period underwear.” ???Why this matters: ??Period care & sustainability?are rarely discussed together, yet disposable products create?massive waste. ??Real-time tracking?empowers users to?make informed choices?for both their health & the planet. ? More?tech-driven innovation?in?femtech & sustainability?is exactly what we need. ?? A simple shift in?product choice?can have a?huge impact—and?@Asan is making that shift easier than ever. Who else wants to see?more innovation?at the intersection of?women’s health & sustainability???? #Femtech #Sustainability #PeriodCare #EcoFriendly #HealthTech #MenstrualHealth #Innovation

???Autoimmune diseases disproportionately affect women—yet support remains lacking. ???80% of the 50M+ Americans with autoimmune diseases are women.?Certain conditions are?16x more common?in women than men. And yet, the?connection between autoimmune disease & hormonal health?is still widely overlooked. ???WellTheory?is stepping up with a?new program?designed to support women navigating this?bidirectional link—addressing conditions like?PCOS, endometriosis, postpartum hormonal shifts, hypothyroidism, perimenopause, menopause, and more. As?Ellen Rudolph, CEO & Co-founder, shares: ???“As a woman who began suffering with an autoimmune disease in my mid-20s, who went on to learn that multiple hormonal issues were one of the root causes of my diagnosis, it was important to create a program aimed at helping other women navigate this oftentimes long and frustrating journey to find solutions.” ???Why this matters: ? Women are often?dismissed or misdiagnosed?when seeking care for autoimmune & hormonal health. ? Addressing the?root causes—not just symptoms—can improve?outcomes & quality of life. ? More?holistic, patient-centered approaches?like this are needed in?women’s healthcare. ?? A much-needed step toward?better support & solutions?for women dealing with?complex, chronic health challenges. #AutoimmuneHealth #HormonalHealth #WomensHealth #Femtech #HealthTech #ChronicIllness #PCOS #Endometriosis

???Tampons & Heavy Metals: What’s the Real Risk? Remember that?study last year?from?University of California, Berkeley & Columbia University?that found?small amounts of metals—including?lead & arsenic—in?14 tampon brands?worldwide? ?? Now, the?FDA has stepped in. Their?initial literature review?found?no cause for concern—but the real test is yet to come. ???What’s next? ? A?second phase?is now underway: an?independent lab study?to determine if metals from tampons are?released or absorbed in the body. ???Why this matters: ?? Research on menstrual products & health?is still lacking ?? Transparency in product safety?is crucial ?? Consumers deserve?clear, science-backed answers With growing scrutiny on?feminine care products, this review could be a?turning point for safety standards. Let’s hope for?definitive answers—and more?research in women’s health. #Femtech #WomensHealth #MenstrualHealth #ProductSafety #FDA #Innovation

???Medical gaslighting is real—and it’s disproportionately affecting women. For too many women, navigating the healthcare system isn’t just complicated—it’s?dismissive. Symptoms are?trivialized, misdiagnosed, or brushed off as anxiety—a phenomenon known as?medical gaslighting. Nicoletta Sozansky, BCPA, knows this firsthand. When she first experienced health issues in her early 30s, her symptoms were?dismissed?as stress or a simple viral infection—an all-too-common reality for women seeking care. Instead of accepting the status quo, she took action. ?? Her experience led her to create?Healthcare Redefined, a?concierge care service specializing in women’s health advocacy. The goal? To ensure that?women’s concerns are heard, validated, and addressed with the care they deserve. ???Why this matters: ?? Studies show that women’s pain is more likely to be?underestimated?by healthcare providers. ?? Women are more likely to be?misdiagnosed?for conditions like heart disease and autoimmune disorders. ?? Advocacy and?patient-centered care?can make all the difference in?outcomes, access, and quality of care. ?? Healthcare Redefined is?turning frustration into action—because?every woman deserves to be heard. #Femtech #MedicalGaslighting #WomensHealth #HealthAdvocacy #PatientCenteredCare #Innovation

???Fueling the next generation of FemTech giants! “What we see as critical right now for FemTech is small-ticket funding to get this incredible pipeline of startups off the ground.”??? Enter?XX Combinator—a?new equity-free, small grant fund?designed to support?early-stage FemTech startups?before they hit traditional venture capital.?Founded by Valerie Cai, M.D., Yvie Lock, and Lauren Walker, XX Combinator aims to?bridge the funding gap?for founders tackling some of the most pressing?women’s health challenges. ???Why does this matter? ???Access to funding?remains one of the biggest hurdles for FemTech startups. Many solutions addressing reproductive health, hormonal health, maternal care, and more struggle to secure early capital. ???FemTech is booming—but many innovations never make it past the idea stage due to a lack of initial funding. ???Equity-free grants?mean founders can?scale, test, and iterate?without diluting ownership early on. ?? With?XX Combinator, the next?FemTech breakthrough?might just be around the corner. #Femtech #StartupFunding #WomenInTech #HealthTech #Innovation #EquityFree #FundingTheFuture

???Breaking barriers in women's health! Raising?$10M in this economic climate?is no small feat—Twentyeight Health?just did it, proving the?resilience and relevance?of its mission. ???? Arianne Kidder, Seae Ventures. The company has already provided?online prescriptions?for birth control, the morning-after pill, pregnancy tests, and herpes treatment to?100,000+ users—and now, with new?Medicaid partnerships?(Aetna, a CVS Health Company, AmeriHealth, Molina Healthcare), they accept?almost every?commercial insurance and Medicaid plan. ??? As?Bruno Van Tuykom, CEO & Co-founder, puts it: ???"At an inflection point for women's health, we are prepared to meet the moment by continuing to invest in our user experience and expanding our reach nationwide to deliver a real solution to a growing problem." ???Accessible, affordable, and essential care—this is what the future of healthcare should look like. ?? #Femtech #HealthcareAccess #Telemedicine #HealthTech #Medicaid #Funding #WomensHealth

???Revolutionizing IVF!?Conceivable Life Sciences is on a mission to make?IVF more accessible and affordable—and they’re doing it with the?world’s first automated IVF lab. ???? Now, with a?$18M Series A?led by?ARTIS Ventures?(bringing total funding to?$39M), Conceivable is set to transform fertility treatment ahead of its?2026 US launch. ????? ???Why does this matter??IVF labs have remained largely?manual?and?artisanal?for decades. Conceivable is?changing the game?with automation, AI, robotics, and machine vision—bringing IVF into the future. As?Alejandro Chavez-Badiola, MD, PhD, Chief Product Officer, explains: ???“Despite significant clinical advances, IVF labs remain largely manual and lacking the kind of automation that has transformed other branches of advanced medicine.” ???“Even in early testing, our clinical outcomes rival the best IVF labs in the world. As we expand access, we anticipate even better results, heralding a new chapter in IVF.” ???A game-changer for fertility care—and a major step toward democratizing access to IVF. ?? #Femtech #IVF #FertilityInnovation #HealthTech #AI #Automation #Funding #FutureOfHealthcare

???Big news in femtech!?Lady Technologies, the company behind the fertility tracker and pelvic floor trainer?kegg, has just secured a?$6.5M Series A?to expand its vaginal health platform! ???? Led by?Relentless Consumer Partners, this funding will push Lady Technologies beyond conception insights—giving women?unparalleled access?to their intimate health data. Kristina Cahojova Founder & CEO, shared: ???"I was shocked that women were being asked to determine changes in cervical mucus using their fingers. I set out to build a technology-driven product, to change the status quo and enable every woman to have total agency over her own body." ???"Our unique form factor allowed us to collect the largest dataset on cervical fluid changes, enabling us to develop the first comprehensive vaginal health platform." This is a?huge?step forward for?women’s health innovation—data-driven, tech-powered, and breaking barriers. ???? #Femtech #WomenInTech #Innovation #VaginalHealth #Funding #HealthTech

???Improving access to fertility care starts with reducing costs. Granata Bio?is committed to making fertility treatments more affordable by identifying and developing?new therapeutic solutions. With their latest funding, they are?accelerating the development of their current and future pipeline?to better serve fertility patients across North America. ???“Granata Bio is committed to improving access for fertility patients by identifying and developing new therapeutic solutions. With this new funding, we are well-positioned to accelerate the development of our current and future pipeline.”?–?Evan Sussman Bio Since its founding in 2018, Granata Bio has worked to?reduce the cost of IVF medications, which have increased by?50%?since 2014, while fertility insurance coverage in the U.S. remains?patchy—leaving many patients bearing the burden of steep costs or unable to afford treatment altogether. Granata Bio’s goal is to change that, providing?greater access to affordable fertility care?for all. ?? #FertilityCare #IVF #WomensHealth #HealthcareInnovation #AccessToCare #GranataBio